<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04937010</url>
  </required_header>
  <id_info>
    <org_study_id>REB21-0839</org_study_id>
    <nct_id>NCT04937010</nct_id>
  </id_info>
  <brief_title>Occipital Nerve Stimulation in Trigeminal Autonomic Cephalgias</brief_title>
  <official_title>Efficacy and Safety of Occipital Nerve Stimulation in Trigeminal Autonomic Cephalalgias: A Double-blind, Phase II, Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alberta Health Services, Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alberta Health Services, Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the efficacy of occipital nerve stimulation (ONS)&#xD;
      in the treatment of chronic trigeminal autonomic cephalalgias (TACs).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several open studies and case series have shown improvement in pain scores using ONS&#xD;
      specifically for cluster headache, which is the most common of the TACs. However,&#xD;
      neuromodulation in the treatment of pain disorders is subject to strong placebo effect and&#xD;
      bias, and the lack of controlled studies in this population makes its true efficacy unknown.&#xD;
      Therefore, we plan to study ONS in a population of patients with chronic TACs using a&#xD;
      double-blind, randomized, controlled, cross-over study. Using sub-threshold stimulation&#xD;
      parameters, meaning patients will not know when therapeutic stimulation is active, subjects&#xD;
      will rate their pain and quality of life during both therapeutic and sham stimulation&#xD;
      periods. Following the cross-over period, all subjects will undergo therapeutic stimulation&#xD;
      for 1-year in order to gauge long-term effects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in headache frequency</measure>
    <time_frame>6 months</time_frame>
    <description>Change in frequency of headaches</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety of Occipital Nerve Stimulation</measure>
    <time_frame>6 months</time_frame>
    <description>Any adverse events with stimulation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Trigeminal Autonomic Cephalgia</condition>
  <arm_group>
    <arm_group_label>Industry standard stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard sub threshold stimulation parameters</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Occipital nerve stimulator implant</intervention_name>
    <description>Implantation of occipital nerve stimulator and different stimulation parameters</description>
    <arm_group_label>Experimental stimulation</arm_group_label>
    <arm_group_label>Industry standard stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Meets ICHD-3 diagnostic criteria for the chronic form of one of the trigeminal&#xD;
             autonomic cephalgias (outlined below), as determined by the treating neurologist.&#xD;
&#xD;
          -  Failed standard medical management, meaning at least 3 conventional preventative&#xD;
             therapies.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of uncontrolled or untreated psychiatric disease&#xD;
&#xD;
          -  Presence of medical contraindications to surgery&#xD;
&#xD;
          -  Patient does not consent to surgery&#xD;
&#xD;
          -  Non-English speaking&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 16, 2021</study_first_submitted>
  <study_first_submitted_qc>June 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>June 16, 2021</last_update_submitted>
  <last_update_submitted_qc>June 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alberta Health Services, Calgary</investigator_affiliation>
    <investigator_full_name>Fady Girgis</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <keyword>Occipital Nerve Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trigeminal Autonomic Cephalalgias</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

